|
1
|
Gordon R: Skin cancer: An overview of
epidemiology and risk factors. Semin Oncol Nurs. 29:160–169. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Linares MA, Zakaria A and Nizran P: Skin
cancer. Prim Care. 42:645–659. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Glass AG and Hoover RN: The emerging
epidemic of melanoma and squamous cell skin cancer. JAMA.
262:2097–2100. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dubas LE and Ingraffea A: Nonmelanoma skin
cancer. Facial Plast Surg Clin North Am. 21:43–53. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Parekh V and Seykora JT: Cutaneous
squamous cell carcinoma. Clin Lab Med. 37:503–525. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Green AC and Olsen CM: Cutaneous squamous
cell carcinoma: An epidemiological review. Br J Dermatol.
177:373–381. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Leiter U, Gutzmer R, Alter M, Ulrich C,
Lonsdorf AS, Sachse MM and Hillen U: Cutaneous squamous cell
carcinoma. Hautarzt. 67:857–866. 2016.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Prieto-Granada C and Rodriguez-Waitkus P:
Cutaneous squamous cell carcinoma and related entities:
Epidemiology, clinical and histological features, and basic science
overview. Curr Probl Cancer. 39:206–215. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thompson AK, Kelley BF, Prokop LJ, Murad
MH and Baum CL: Risk factors for cutaneous squamous cell carcinoma
recurrence, metastasis and disease-specific death: A systematic
review and meta-analysis. JAMA Dermatol. 152:419–428. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Trodello C, Pepper JP, Wong M and Wysong
A: Cisplatin and cetuximab treatment for metastatic cutaneous
squamous cell carcinoma: A systematic review. Dermatol Surg.
43:40–49. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wells JL III and Shirai K: Systemic
therapy for squamous cell carcinoma of the skin in organ transplant
recipients. Am J Clin Oncol. 35:498–503. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Han C, Seebacher NA, Hornicek FJ, Kan Q
and Duan Z: Regulation of microRNAs function by circular RNAs in
human cancer. Oncotarget. 8:64622–64637. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Self-Fordham JB, Naqvi AR, Uttamani JR,
Kulkarni V and Nares S: MicroRNA: Dynamic regulators of macrophage
polarization and plasticity. Front Immunol. 8:10622017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dang RY, Liu FL and Li Y: Circular RNA
hsa_circ_0010729 regulates vascular endothelial cell proliferation
and apoptosis by targeting the miR-186/HIF-1α axis. Biochem Biophys
Res Commun. 490:104–110. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu C, Wang J, Hu Y, Xie H, Liu M and Tang
H: Upregulation of kazrin F by miR-186 suppresses apoptosis but
promotes epithelial-mesenchymal transition to contribute to
malignancy in human cervical cancer cells. Chin J Cancer Res.
29:45–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang JJ, Wang DD, Du CX and Wang Y: Long
noncoding RNA ANRIL promotes cervical cancer development by acting
as a sponge of miR-186. Oncol Res. May 22–2017.(Epub ahead of
print). View Article : Google Scholar
|
|
17
|
He X, Ping J and Wen D: MicroRNA-186
regulates the invasion and metastasis of bladder cancer via
vascular endothelial growth factor C. Exp Ther Med. 14:3253–3258.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Niu Q, Li X, Xia D, Jiang Y, Tian Z, Bian
C, Zhang C, Liu P, Zhang F, Yang Y and Wang G: MicroRNA-186 affects
the proliferation of tumor cells via yes-associated protein 1 in
the occurrence and development of pancreatic cancer. Exp Ther Med.
14:2094–2100. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Chen F, Zhao M, Yang Z, Li J,
Zhang S, Zhang W, Ye L and Zhang X: The long noncoding RNA HULC
promotes liver cancer by increasing the expression of the HMGA2
oncogene via sequestration of the microRNA-186. J Biol Chem.
292:15395–15407. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shakeri R, Kheirollahi A and Davoodi J:
Apaf-1: Regulation and function in cell death. Biochimie.
135:111–125. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
De Zio D, Maiani E and Cecconi F: Apaf1 in
embryonic development-shaping life by death and more. Int J Dev
Biol. 59:33–39. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hickman ES and Helin K: The regulation of
APAF1 expression during development and tumourigenesis. Apoptosis.
7:167–171. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu N, Sun YY, Zhang XW, Chen S, Wang Y,
Zhang ZX, Song SW, Qiu GB and Fu WN: Oncogenic miR-23a in
pancreatic ductal adenocarcinogenesis via inhibiting APAF1. Dig Dis
Sci. 60:2000–2008. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li J, Li Q, Huang H, Li Y, Li L, Hou W and
You Z: Overexpression of miRNA-221 promotes cell proliferation by
targeting the apoptotic protease activating factor-1 and indicates
a poor prognosis in ovarian cancer. Int J Oncol. Mar 7–2017.(Epub
ahead of print).
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yesantharao P, Wang W, Ioannidis NM,
Demehri S, Whittemore AS and Asgari MM: Cutaneous squamous cell
cancer (cSCC) risk and the human leukocyte antigen (HLA) system.
Hum Immunol. 78:327–335. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Karia PS, Morgan FC, Ruiz ES and Schmults
CD: Clinical and incidental perineural invasion of cutaneous
squamous cell carcinoma: A systematic review and pooled analysis of
outcomes data. JAMA Dermatol. 153:781–788. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Grossi I, Salvi A, Abeni E, Marchina E and
De Petro G: Biological function of MicroRNA193a-3p in health and
disease. Int J Genomics. 2017:59131952017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mulholland EJ, Dunne N and McCarthy HO:
MicroRNA as therapeutic targets for chronic wound healing. Mol Ther
Nucleic Acids. 8:46–55. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wei F, Yang S and Wang S: MicroRNAs: A
critical regulator under mechanical force. Histol Histopathol.
33:335–342. 2018.PubMed/NCBI
|
|
31
|
Celano M, Rosignolo F, Maggisano V, Pecce
V, Iannone M, Russo D and Bulotta S: MicroRNAs as biomarkers in
thyroid carcinoma. Int J Genomics. 2017:64965702017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shomali N, Mansoori B, Mohammadi A,
Shirafkan N, Ghasabi M and Baradaran B: MiR-146a functions as a
small silent player in gastric cancer. Biomed Pharmacother.
96:238–245. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Negoi I, Hostiuc S, Sartelli M, Negoi RI
and Beuran M: MicroRNA-21 as a prognostic biomarker in patients
with pancreatic cancer-A systematic review and meta-analysis. Am J
Surg. 214:515–524. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jang MH, Kim HJ, Gwak JM, Chung YR and
Park SY: Prognostic value of microRNA-9 and microRNA-155 expression
in triple-negative breast cancer. Hum Pathol. 68:69–78. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Neu J, Dziunycz PJ, Dzung A, Lefort K,
Falke M, Denzler R, Freiberger SN, Iotzova-Weiss G, Kuzmanov A,
Levesque MP, et al: miR-181a decelerates proliferation in cutaneous
squamous cell carcinoma by targeting the proto-oncogene KRAS. PLoS
One. 12:e01850282017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fleming JL, Gable DL, Samadzadeh-Tarighat
S, Cheng L, Yu L, Gillespie JL and Toland AE: Differential
expression of miR-1, a putative tumor suppressing microRNA, in
cancer resistant and cancer susceptible mice. PeerJ. 1:e682013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lefort K, Brooks Y, Ostano P, Cario-André
M, Calpini V, Guinea-Viniegra J, Albinger-Hegyi A, Hoetzenecker W,
Kolfschoten I, Wagner EF, et al: A miR-34a-SIRT6 axis in the
squamous cell differentiation network. EMBO J. 32:2248–2263. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yamane K, Jinnin M, Etoh T, Kobayashi Y,
Shimozono N, Fukushima S, Masuguchi S, Maruo K, Inoue Y, Ishihara
T, et al: Down-regulation of miR-124/-214 in cutaneous squamous
cell carcinoma mediates abnormal cell proliferation via the
induction of ERK. J Mol Med (Berl). 91:69–81. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xu N, Zhang L, Meisgen F, Harada M,
Heilborn J, Homey B, Grandér D, Ståhle M, Sonkoly E and Pivarcsi A:
MicroRNA-125b down-regulates matrix metallopeptidase 13 and
inhibits cutaneous squamous cell carcinoma cell proliferation,
migration, and invasion. J Biol Chem. 287:29899–29908. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
He J, Feng X, Hua J, Wei L, Lu Z, Wei W,
Cai H, Wang B, Shi W, Ding N, et al: miR-300 regulates cellular
radiosensitivity through targeting p53 and apaf1 in human lung
cancer cells. Cell Cycle. 16:1943–1953. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yeung Au CL, Co NN, Tsuruga T, Yeung TL,
Kwan SY, Leung CS, Li Y, Lu ES, Kwan K, Wong KK, et al: Exosomal
transfer of stroma-derived miR21 confers paclitaxel resistance in
ovarian cancer cells through targeting APAF1. Nat Commun.
7:111502016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Song S, Seo HH, Lee SY, Lee CY, Lee J, Yoo
KJ, Yoon C, Choi E, Hwang KC and Lee S: MicroRNA-17-mediated
down-regulation of apoptotic protease activating factor 1
attenuates apoptosome formation and subsequent apoptosis of
cardiomyocytes. Biochem Biophys Res Commun. 465:299–304. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zang YS, Zhong YF, Fang Z, Li B and An J:
MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin
via negative regulation of Apaf-1 expression. Cancer Gene Ther.
19:773–778. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shang J, Yang F, Wang Y, Wang Y, Xue G,
Mei Q, Wang F and Sun S: MicroRNA-23a antisense enhances
5-fluorouracil chemosensitivity through APAF-1/caspase-9 apoptotic
pathway in colorectal cancer cells. J Cell Biochem. 115:772–784.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zou M, Lu N, Hu C, Liu W, Sun Y, Wang X,
You Q, Gu C, Xi T and Guo Q: Beclin 1-mediated autophagy in
hepatocellular carcinoma cells: Implication in anticancer
efficiency of oroxylin A via inhibition of mTOR signaling. Cell
Signal. 24:1722–1732. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ravikumar B, Sarkar S, Davies JE, Futter
M, Garcia-Arencibia M, Green-Thompson ZW, Jimenez-Sanchez M,
Korolchuk VI, Lichtenberg M, Luo S, et al: Regulation of mammalian
autophagy in physiology and pathophysiology. Physiol Rev.
90:1383–1435. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Klionsky DJ, Abeliovich H, Agostinis P,
Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA,
Ballabio A, et al: Guidelines for the use and interpretation of
assays for monitoring autophagy in higher eukaryotes. Autophagy.
4:151–175. 2008. View Article : Google Scholar : PubMed/NCBI
|
